View More View Less
  • 1 Isfahan University of Medical Sciences Department of Physiology Isfahan Iran
  • | 2 Pasteur Institute of Iran Department of Physiology and Pharmacology Tehran Iran
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $752.00

Several reports indicated the beneficial effects of short-term L-Arginine (L-Arg) administration on atherosclerosis processes. The aim of this study was to evaluate the effect of chronic L-Arg supplementation on serum lipid profile, aortic Fatty Streak (FS) formation, and serum Nitric oxide (NO) concentration in Normal Diet (ND) and High-Cholesterol Diet (HCD) fed rabbits. 24 male rabbits were randomly divided into four groups (n=6 in each group) (i): ND for seven months; (ii): ND for 1 month plus ND + L-Arg for six months; (iii): HCD (1%) for 1 month plus HCD (0.5%) for six months; (iv): HCD (1%) for 1 month plus HCD (0.5%) + L-Arg for six months. At the end of the study, histological evaluation of aortic FS formation was performed. Blood samples were taken for serum lipid profile and NO concentrations. L-Arg did not change serum total cholesterol, triglyceride, LDL and LDL/HDL ratio in normal and hypercholesterolemic rabbits (p>0.05). Histological examination of thoracic aortae revealed that the HCD group had higher FS formation compared to the ND group (2.1 ± 0.16 vs. 0 ± 0; respectively; p<0.05) and L-Arg supplementation did not attenuate FS formation in the HCD group (1.93 ± 0.17 compare to 2.1 ± 0.16; p>0.05). Serum NO level in the HCD group was higher than ND groups (p<0.05). Chronic L-Arg supplementation did not alter serum NO concentration either in the hypercholesterolemic or in the ND group (p>0.05). It seems that chronic L-Arg supplementation does not have beneficial effects on aortic fatty streak formation, serum lipids and NO concentrations in this model of experimental hypercholesterolemia.

  • Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS: Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men. J. Am. Coll. Cardiol. 26, 1054–1061 (1995)

    Celermajer D.S. , 'Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men ' (1995 ) 26 J. Am. Coll. Cardiol. : 1054 -1061.

    • Search Google Scholar
  • Aji W, Ravalli S, Szabolcs M, Jiang XC, Sciacca RR, Michler RE, Cannon PJ: L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation 95, 430–437 (1997)

    Cannon P.J. , 'L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice ' (1997 ) 95 Circulation : 430 -437.

    • Search Google Scholar
  • Behr-Roussel D, Rupin A, Simonet S, Bonhomme E, Coumailleau S, Cordi A, Serkiz B, Fabiani JN, Verbeuren TJ: Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation 102, 1033–1038 (2000)

    Verbeuren T.J. , 'Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits ' (2000 ) 102 Circulation : 1033 -1038.

    • Search Google Scholar
  • Boger RH, Bode-Boger SM: The clinical pharmacology of L-arginine. Annu. Rev. Pharmacol. Toxicol. 41, 79–99 (2001)

    Bode-Boger S.M. , 'The clinical pharmacology of L-arginine ' (2001 ) 41 Annu. Rev. Pharmacol. Toxicol. : 79 -99.

    • Search Google Scholar
  • Boger RH, Bode-Boger SM, Phivthong-ngam L, Brandes RP, Schwedhelm E, Mugge A, Bohme M, Tsikas D, Frolich JC: Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis 141, 31–43 (1998).

    Frolich J.C. , 'Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms ' (1998 ) 141 Atherosclerosis : 31 -43.

    • Search Google Scholar
  • Bult H, De Meyer GR, Herman AG: Influence of chronic treatment with a nitric oxide donor on fatty streak development and reactivity of the rabbit aorta. Br. J. Pharmacol. 114, 1371–1382 (1995).

    Herman A.G. , 'Influence of chronic treatment with a nitric oxide donor on fatty streak development and reactivity of the rabbit aorta ' (1995 ) 114 Br. J. Pharmacol. : 1371 -1382.

    • Search Google Scholar
  • Calver A, Collier J, Vallance P: Nitric oxide and the control of human vascular tone in health and disease. Eur. J. Med. 2, 48–53 (1993)

    Vallance P. , 'Nitric oxide and the control of human vascular tone in health and disease ' (1993 ) 2 Eur. J. Med. : 48 -53.

    • Search Google Scholar
  • Chen J, Kuhlencordt P, Urano F, Ichinose H, Astern J, Huang PL: Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice. Arterioscler. Thromb. Vasc. Biol. 23, 97–103 (2003)

    Huang P.L. , 'Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice ' (2003 ) 23 Arterioscler. Thromb. Vasc. Biol. : 97 -103.

    • Search Google Scholar
  • Cooke JP: Is atherosclerosis an arginine deficiency disease? J. Investig. Med. 46, 377–380 (1998)

    Cooke J.P. , 'Is atherosclerosis an arginine deficiency disease? ' (1998 ) 46 J. Investig. Med. : 377 -380.

    • Search Google Scholar
  • Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME: Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90, 1168–1172 (1992)

    Billingham M.E. , 'Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit ' (1992 ) 90 J. Clin. Invest. : 1168 -1172.

    • Search Google Scholar
  • Cooke JP, Tsao PS: Arginine: a new therapy for atherosclerosis? Circulation 95, 311–312 (1997)

    Tsao P.S. , 'Arginine: a new therapy for atherosclerosis? ' (1997 ) 95 Circulation : 311 -312.

    • Search Google Scholar
  • Corseaux D, Le Tourneau T, Six I, Ezekowitz MD, Mc Fadden EP, Meurice T, Asseman P, Bauters C, Jude B: Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: inhibition with dietary L-arginine. Circulation 98, 1776–1782 (1998)

    Jude B. , 'Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit: inhibition with dietary L-arginine ' (1998 ) 98 Circulation : 1776 -1782.

    • Search Google Scholar
  • Dhawan V, Handu SS, Nain CK, Ganguly NK: Chronic L-arginine supplementation improves endothelial cell vasoactive functions in hypercholesterolemic and atherosclerotic monkeys. Mol. Cell. Biochem. 269, 1–11 (2005)

    Ganguly N.K. , 'Chronic L-arginine supplementation improves endothelial cell vasoactive functions in hypercholesterolemic and atherosclerotic monkeys ' (2005 ) 269 Mol. Cell. Biochem. : 1 -11.

    • Search Google Scholar
  • Dudek D, Legutko J, Heba G, Bartus S, Partyka L, Huk I, Dembinska-Kiec A, Kaluza GL, Dubiel JS: L-arginine supplementation does not inhibit neointimal formation after coronary stenting in human beings: an intravascular ultrasound study. Am. Heart J. 147, E12 (2004)

    Dubiel J.S. , 'L-arginine supplementation does not inhibit neointimal formation after coronary stenting in human beings: an intravascular ultrasound study ' (2004 ) 147 Am. Heart J. : E12 -.

    • Search Google Scholar
  • Ferlito S, Gallina M, Catassi S, Bisicchia A, Di Salvo MM: Nitrite plasma levels in normolipemic and hypercholesterolemic patients with peripheral occlusive arteriopathy. Panminerva Med. 41, 307–309 (1999)

    Salvo M.M. , 'Nitrite plasma levels in normolipemic and hypercholesterolemic patients with peripheral occlusive arteriopathy ' (1999 ) 41 Panminerva Med. : 307 -309.

    • Search Google Scholar
  • Hayashi T, Juliet PA, Matsui-Hirai H, Miyazaki A, Fukatsu A, Funami J, Iguchi A, Ignarro LJ: l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits. Proc. Natl. Acad. Sci. U.S.A. 102. 13681–13686 (2005)

    Ignarro L.J. , 'l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits ' (2005 ) 102 Proc. Natl. Acad. Sci. U.S.A. : 13681 -13686.

    • Search Google Scholar
  • Herman AG, Moncada S: Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis. Eur. Heart J. (2005)

  • Ignarro LJ, Napoli C: Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr. Diab. Rep. 5, 17–23 (2005)

    Napoli C. , 'Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis ' (2005 ) 5 Curr. Diab. Rep. : 17 -23.

    • Search Google Scholar
  • Javanmard SH, Gheisari Y, Soleimani M, Nematbakhsh M, Monajemi A: Effect of L-arginine on circulating endothelial progenitor cells in hypercholesterolemic rabbits. Int. J. Cardiol. 143, 213–216 (2010)

    Monajemi A. , 'Effect of L-arginine on circulating endothelial progenitor cells in hypercholesterolemic rabbits ' (2010 ) 143 Int. J. Cardiol. : 213 -216.

    • Search Google Scholar
  • Kauser K, da C, V, Fitch R, Mallari C, Rubanyi GM: Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am. J. Physiol Heart Circ. Physiol 278, H1679–H1685 (2000)

    Rubanyi G.M. , 'Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice ' (2000 ) 278 Am. J. Physiol Heart Circ. Physiol : H1679 -H1685.

    • Search Google Scholar
  • Keaney JF Jr.: Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction. Mol. Aspects Med. 21, 99–166 (2000)

    Keaney J.F. , 'Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction ' (2000 ) 21 Mol. Aspects Med. : 99 -166.

    • Search Google Scholar
  • Minor RL Jr., Myers PR, Guerra R Jr., Bates JN, Harrison DG: Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J. Clin. Invest. 86, 2109–2116 (1990)

    Harrison D.G. , 'Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta ' (1990 ) 86 J. Clin. Invest. : 2109 -2116.

    • Search Google Scholar
  • Nematbakhsh M, Haghjooyjavanmard S, Mahmoodi F, Monajemi AR: The prevention of endothelial dysfunction through endothelial cell apoptosis inhibition in a hypercholesterolemic rabbit model: the effect of L-arginine supplementation. Lipids Health Dis. 7, 27 (2008)

    Monajemi A.R. , 'The prevention of endothelial dysfunction through endothelial cell apoptosis inhibition in a hypercholesterolemic rabbit model: the effect of L-arginine supplementation ' (2008 ) 7 Lipids Health Dis. : 27 -.

    • Search Google Scholar
  • Nematbakhsh M, Khazaei M: The effect of estrogen on serum nitric oxide concentrations in normotensive and DOCA Salt hypertensive ovariectomized rats. Clin. Chim. Acta. 344, 53–57 (2004)

    Khazaei M. , 'The effect of estrogen on serum nitric oxide concentrations in normotensive and DOCA Salt hypertensive ovariectomized rats ' (2004 ) 344 Clin. Chim. Acta. : 53 -57.

    • Search Google Scholar
  • Oomen CM, van Erk MJ, Feskens EJ, Kok FJ, Kromhout D: Arginine intake and risk of coronary heart disease mortality in elderly men. Arterioscler. Thromb. Vasc. Biol. 20, 2134–2139 (2000)

    Kromhout D. , 'Arginine intake and risk of coronary heart disease mortality in elderly men ' (2000 ) 20 Arterioscler. Thromb. Vasc. Biol. : 2134 -2139.

    • Search Google Scholar
  • Pakala R, Dilcher C, Baffour R, Hellinga D, Seabron R, Joner M, Kolodgie F, Virmani R, Waksman R: Peroxisome proliferator-activated receptor gamma ligand pioglitazone alters neointimal composition in a balloon-denuded and radiated hypercholesterolemic rabbit. J. Cardiovasc. Pharmacol. 48, 299–305 (2006)

    Waksman R. , 'Peroxisome proliferator-activated receptor gamma ligand pioglitazone alters neointimal composition in a balloon-denuded and radiated hypercholesterolemic rabbit ' (2006 ) 48 J. Cardiovasc. Pharmacol. : 299 -305.

    • Search Google Scholar
  • Rasmusen C, Moinard C, Martin C, Tricottet V, Cynober L, Couderc R: L-arginine plus atorvastatin for prevention of atheroma formation in genetically hypercholesterolaemic rabbits. Br. J. Nutr. 97, 1083–1089 (2007)

    Couderc R. , 'L-arginine plus atorvastatin for prevention of atheroma formation in genetically hypercholesterolaemic rabbits ' (2007 ) 97 Br. J. Nutr. : 1083 -1089.

    • Search Google Scholar
  • Ross R: Atherosclerosis is an inflammatory disease. Am. Heart J. 138, S419–S420 (1999)

    Ross R. , 'Atherosclerosis is an inflammatory disease ' (1999 ) 138 Am. Heart J. : S419 -S420.

    • Search Google Scholar
  • Simonet S, Rupin A, Badier-Commander C, Coumailleau S, Behr-Roussel D, Verbeuren TJ: Evidence for superoxide anion generation in aortas of cholesterol-fed rabbits treated with L-arginine. Eur. J. Pharmacol. 492, 211–216 (2004)

    Verbeuren T.J. , 'Evidence for superoxide anion generation in aortas of cholesterol-fed rabbits treated with L-arginine ' (2004 ) 492 Eur. J. Pharmacol. : 211 -216.

    • Search Google Scholar
  • Wilcox JN, Subramanian RR, Sundell CL, Tracey WR, Pollock JS, Harrison DG, Marsden PA: Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler. Thromb. Vasc. Biol. 17, 2479–2488 (1997)

    Marsden P.A. , 'Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels ' (1997 ) 17 Arterioscler. Thromb. Vasc. Biol. : 2479 -2488.

    • Search Google Scholar
  • Zhao SP, Yang J, Li J, Dong SZ, Wu ZH: Effect of niacin on LXRalpha and PPARgamma expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits. Int. J. Cardiol. 124, 172–178 (2008)

    Wu Z.H. , 'Effect of niacin on LXRalpha and PPARgamma expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits ' (2008 ) 124 Int. J. Cardiol. : 172 -178.

    • Search Google Scholar

The author instruction is available in PDF.

Please, download the file from HERE

Senior editors

Editor(s)-in-Chief: Rosivall, László

Honorary Editor(s)-in-Chief): Monos, Emil

Managing Editor(s): Bartha, Jenő; Berhidi, Anna

Co-editor(s): Koller, Ákos; Lénárd, László; Szénási, Gábor

Assistant Editor(s): G. Dörnyei (Budapest), Zs. Miklós (Budapest), Gy. Nádasy (Budapest)

Hungarian Editorial Board

      Benedek, György (Szeged)
      Benyó, Zoltán (Budapest)
      Boros, Mihály (Szeged)
      Chernoch, László (Debrecen)
      Détári, László (Budapest)
      Hamar, János (Budapest)
      Hantos, Zoltán (Szeged)
      Hunyady, László (Budapest)
      Imre, Sándor (Debrecen)
      Jancsó, Gábor (Szeged)
      Karádi, Zoltán (Pécs)
      Kovács, László (Debrecen)
      Palkovits, Miklós (Budapest)
      Papp, Gyula (Szeged)
      Pavlik, Gábor (Budapest)
      Spät, András (Budapest)
      Szabó, Gyula (Szeged)
      Szelényi, Zoltán (Pécs)
      Szolcsányi, János (Pécs)
      Szollár, Lajos (Budapest)
      Szücs, Géza (Debrecen)
      Telegdy, Gyula (Szeged)
      Toldi, József (Szeged)
      Tósaki, Árpád (Debrecen)

International Editorial Board

      R. Bauer (Jena)
      W. Benjelloun (Rabat)
      A. W. Cowley Jr. (Milwaukee)
      D. Djuric (Belgrade)
      C. Fry (London)
      S. Greenwald (London)
      O. Hänninen (Kuopio)
      H. G. Hinghofer-Szalkay (Graz)
      Th. Kenner (Graz)
      Gy. Kunos (Richmond)
      M. Mahmoudian (Tehran)
      T. Mano (Seki, Gifu)
      G. Navar (New Orleans)
      H. Nishino (Nagoya)
      O. Petersen (Liverpool)
      U. Pohl (Münich)
      R. S. Reneman (Maastricht)
      A. Romanovsky (Phoenix)
      G. M. Rubanyi (Richmond)
      T. Sakata (Oita)
      A. Siddiqui (Karachi)
      Cs. Szabo (Beverly)
      E. Vicaut (Paris)
      N. Westerhof (Amsterdam)
      L. F. Zhang (Xi'an)

Editorial Office:
Akadémiai Kiadó Zrt.
Prielle Kornélia u. 21–35, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Physiologica Hungarica
Semmelweis University, Faculty of Medicine Institute of Pathophysiology
Nagyvárad tér 4, H-1089 Budapest, Hungary
Phone/Fax: +36-1-2100-100
E-mail: aph@semmelweis-univ.hu

Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • EMBASE/Excerpta Medica
  • Global Health
  • Index Copernicus
  • Index Medicus
  • Medline
  • Referativnyi Zhurnal
  • Science Citation Index Expanded
  • SCOPUS

 

Acta Physiologica Hungarica
Language English
Size  
Year of
Foundation
1950
Publication
Programme
changed title
Volumes
per Year
 
Issues
per Year
 
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0231-424X (Print)
ISSN 1588-2683 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 2 0 0
May 2021 9 0 0
Jun 2021 2 0 0
Jul 2021 2 0 0
Aug 2021 11 0 0
Sep 2021 5 0 0
Oct 2021 5 0 0